<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v10i6.15534</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Flow Rate Control and Optimization of RCA Infusion System Based on ADRC and Two-Stage Calcium Supplementation Model</title><url>https://artdesignp.com/journal/JCNR/10/6/10.26689/jcnr.v10i6.15534</url><author>XuChao,DingDamin,WangChaobin</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>10</volume><issue>6</issue><history><date date-type="pub"><published-time>2026-06-30</published-time></date></history><abstract>Based on the established two-stage mathematical model of Regional Citrate Anticoagulation (RCA), an automated RCA infusion system is constructed. Aiming at the flow rate accuracy problem of peristaltic pumps under variable pressure environments, a flow rate control algorithm based on Active Disturbance Rejection Control (ADRC) is designed, combined with pressure compensation and surface calibration methods. The experimental results show that this method can achieve high-precision infusion under different pressure differences and meet clinical requirements.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Mehta R, McDonald B, Aguilar M, et al., 1990, Regional Citrate Anticoagulation for Continuous Arteriovenous Hemodialysis in Critically Ill Patients. Kidney International, 38: 976–981.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Oudemans-Van S, Bosman R, Koopmans M, et al., 2009, Citrate Anticoagulation for Continuous Venovenous Hemofiltration. Critical Care Medicine, 37: 545–552.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Khwaja A, 2012, KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clinical Practice, 120: c179–c184.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Zheng Y, Xu Z, Zhu Q, et al., 2013, Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury. PLoS One, 8(6): e65992.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Han J, 1998, Active Disturbance Rejection Control and Its Application. Control and Decision, 13(1): 19–23.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Han J, Zhang W, 1999, Active Disturbance Rejection Control for Large Time-Delay Systems. Control and Decision, 14(4): 354–358.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Gong D, Ji D, Xie H, et al., 2001, The Effects of Dialysate and Ultrafiltration Flow Rate on Solute Clearance During Continuous Renal Replacement Therapy. Zhonghua Nei Ke Za Zhi, 40: 183–186.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
